Weight Loss and Obesity Management Market SWOT Analysis, Key Companies, CAGR Status by 2028 | Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd

Obesity is characterized as the accumulation of excess body fat. Diseases and the promotion of an unhealthy lifestyle are two main contributors to obesity around the world. Drugs, dietary supplements, bariatric surgery (weight reduction surgery), and exercise are some of the techniques used to treat weight loss and obesity. As per the World Health Organization (WHO), a person is overweight if their BMI is greater than or equal to 25, and obese if their BMI is greater than or equal to 30.

In 2019, the global weight loss and obesity management market is projected to be worth US$ 170.0 billion, growing at a CAGR of 7.1 percent during the forecast period (2019-2027).

Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/3448

Rising prevalence of obesity in developing and developing economies around the world is expected to drive growth of the global weight loss and obesity management market during the forecast period. As per the World Federation of Obesity, nearly 27.4 million children in India will be obese by 2030, according to estimates. During the forecast period, the exponential rise in childhood obesity in India is projected to raise demand for weight loss and obesity management techniques.

Moreover, the weight loss and obesity management market is projected to rise due to increased research and development, as well as market players' embrace of strategies such as partnerships and the development of new goods to extend their geographic footprint. CY Biotech was granted exclusive manufacturing and marketing rights to its anti-obesity agent lorcaserin hydrochloride (lorcaserin) in China by Eisai Co., Ltd. in July 2018.

Additionally, factors such as poor visibility in low-income countries and the high cost of weight loss and obesity management goods and services are likely to stymie growth of the global weight loss and obesity management market over the forecast period.

Want to "ahead" with your competiors request a PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3448

The weight loss and obesity management market is projected to expand due to increased acceptance of strategies by key players in the market.

Manufacturers are focused on corporate mergers, acquisitions, and partnerships to improve their market presence. In October 2018, Eisai Co., Ltd. agreed to award exclusive production and marketing rights for its anti-obesity agent, lorcaserin hydrochloride, to Eurofarma Laboratories S.A. in 17 Latin American and Caribbean countries, except Brazil.

Key Players

Key companies contributing in the global weight loss and obesity management market are Brunswick Corporation, Amer Sports, Apollo Endosurgery (U.S.), Eisai Co., Ltd., Herbalife Ltd., Kellogg Company, NutriSystem, Inc., Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Medtronic, Life Time Fitness Inc., VIVUS Inc., Johnson & Johnson Services, Inc., Equinox, Inc., F. Hoffmann-La Roche Ltd, Ethicon Inc., Duke Products & Services & Fitness Center, and Cybex International.

Reasons to Purchase this Report

• Current and future of global Weight Loss and Obesity Management market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

• Regions/countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3448
Table of Content

Global Weight Loss and Obesity Management Market Research Report

Section 1: Global Weight Loss and Obesity Management Industry Overview

Section 2: Global Economic Impact on Weight Loss and Obesity Management Industry

Section 3: Global Market Competition by Industry Producers

Section 4: Global Productions, Revenue (Value), according to Regions

Section 5: Global Supplies (Production), Consumption, Export, Import, geographically

Section 6: Global Productions, Revenue (Value), Price Trend, Product Type

Section 7: Global Market Analysis, on the basis of Application

Section 8: Weight Loss and Obesity Management Market Pricing Analysis

Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.